- News & Analysis
Page 911
Epizyme raises $77m in flotation
Epizyme sold 5.1 million shares at $15 each compared to plans to offer 4.285 million shares at between $13 and $15 each.
Jun 1, 2013QB3 gains corporate and venture backing
Since it was founded in 2000, QB3 has worked to spin out research from UC Berkeley, UC Santa Cruz and UCSF into standalone companies or to unite researchers with larger companies.
Jun 1, 2013Bayer and Roche team up with QB3
Global drug giants form alliances to enable start-ups in the San Francisco Bay Area.
Jun 1, 2013Effector Therapeutics starts with $45m
US-based biopharmaceutical company raises Series A financing from investors including Novartis Venture Funds.
May 31, 2013Transgene ups anti with Elsalys Biotech
French biopharmaceutical company Transgene invests in antibody start-up
May 31, 2013About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin